Valuation: Eurofins-Cerep

Market Cap 82.22M 93.57M 76.74M 70.43M 132M 8.96B 135M 910M 356M 4.43B 351M 344M 15.33B P/E 2024 *
-
P/E 2025 -
Enterprise Value 61.18M 69.63M 57.11M 52.41M 98.11M 6.67B 101M 677M 265M 3.3B 261M 256M 11.41B EV / Sales 2024
2.02x
EV / Sales 2025 1.67x
Free-Float
4.22%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 10/04/2024
Director TitleAgeSince
Chairman - 10/08/2023
Director/Board Member - 22/05/2024
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+0.01%+4,900.50% - - 93.68M
+2.61%+7.16%-0.93%+13.78% 47.88B
-0.03%-0.52%+391.98%+593.64% 39.09B
-0.29%+2.93%+7.71%+53.73% 36.75B
+1.41%+23.96%+26.49%+9.97% 40.55B
+1.47%+4.90%+6.48%+43.52% 27.96B
-0.13%+0.81% - - 16.77B
+3.06%+11.13%+31.03%+131.83% 15.94B
+0.18%-2.75%+3.22%+9.68% 13.55B
+0.58%+8.90%-1.64%-27.54% 13.81B
Average +0.82%+4.66%+58.04%+103.58% 28.03B
Weighted average by Cap. +0.93%+5.06%+73.59%+124.46%

Financials

2024 2025
Net sales 40.49M 46.08M 37.79M 34.68M 64.93M 4.41B 66.53M 448M 175M 2.18B 173M 169M 7.55B 41.1M 46.77M 38.36M 35.21M 65.9M 4.48B 67.53M 455M 178M 2.22B 176M 172M 7.66B
Net income 7.15M 8.14M 6.68M 6.13M 11.47M 780M 11.76M 79.19M 30.97M 386M 30.57M 29.91M 1.33B 4.78M 5.44M 4.46M 4.1M 7.67M 521M 7.86M 52.94M 20.7M 258M 20.43M 19.99M 892M
Net Debt -17.25M -19.63M -16.1M -14.78M -27.67M -1.88B -28.35M -191M -74.68M -931M -73.72M -72.12M -3.22B -21.03M -23.94M -19.63M -18.02M -33.73M -2.29B -34.56M -233M -91.05M -1.13B -89.88M -87.93M -3.92B
Logo Eurofins-Cerep
Eurofins Cerep specializes in the pre-clinical research of drugs for the pharmaceutical industry. Export accounts for 88.2% of net sales.
Employees
-